An Investigator Initiated Open Label Study Evaluating the Efficacy and Tolerability of Oral Deucravacitinib for the Treatment of Nail Psoriasis
Clinical trial NCT05124080 · COMPLETED
Trial details
- NCT number
- NCT05124080
- Sponsor
- University of Alabama at Birmingham
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-01
- Primary completion
- 2025-12-01
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.